Diagnosis and Molecular Characterization of Potential RNA Binding Protein Involved in the Pathogenesis of Liver Ischemia Reperfusion Injury
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified three key RNA binding proteins (DNAJB1, CCNL1, BTG2) as diagnostic markers for liver ischemia-reperfusion injury. These proteins are linked to immune cell infiltration and inflammatory pathways, offering new therapeutic insights.
Area Of Science
- Hepatology
- Immunology
- Bioinformatics
Background
- Liver ischemia-reperfusion injury is a frequent complication after liver surgery, potentially leading to severe outcomes like surgical failure.
- Identifying diagnostic markers and understanding the pathogenesis of liver ischemia-reperfusion injury are critical clinical challenges.
Purpose Of The Study
- To identify novel RNA binding proteins as diagnostic markers for liver ischemia-reperfusion injury.
- To explore the pathogenesis and potential therapeutic targets for liver ischemia-reperfusion injury.
Main Methods
- Utilized bioinformatics analysis of Gene Expression Omnibus (GEO) datasets focusing on 1411 candidate RNA binding proteins.
- Constructed and validated a diagnostic model, predicted signaling pathways, and assessed immune cell infiltration.
- Employed single-cell sequencing and machine learning to analyze gene expression profiles and RNA binding domains.
Main Results
- A diagnostic model demonstrated stable efficacy and clinical utility via ROC and DCA curves.
- Identified three key genes: DNAJB1, CCNL1, and BTG2, significantly upregulated in liver ischemia-reperfusion.
- These genes are expressed in immune cells (macrophages, T cells) and associated with inflammatory pathways (e.g., TNF-α).
Conclusions
- The study highlights the critical role of specific RNA binding proteins in liver ischemia-reperfusion injury.
- These findings offer novel insights into the pathogenesis and potential therapeutic strategies for hepatic ischemia-reperfusion injury.

